abstract |
The present invention discloses a piperidinedione compound having a series of tricyclic condensed furan substitutions and its use in the manufacture of a drug for treating a CRBN protein-related disease, specifically a derivative represented by the formula (I). Disclose a compound or a pharmaceutically acceptable salt thereof. [Chemical 1] |